Stocks Gain Despite Hawkish Fed Minutes 📈

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. It's Wednesday, January 4th. I hope you had a great day! Here's what moved the market today: Markets 📈 Stocks managed to close slightly higher after a wild trading session. The S&P 500 [+0.7%], Nasdaq [+0.6%], and Dow [+0.4%] gained after riding in the red for most of the session, and the small-cap Russell 2K [+1.2%] outperformed its large-cap cohorts. Sponsored [Wall Street Legend: The Top 11 Stocks for 2023]( 📈 Louis Navellier’s system has identified 18 stocks that rose 10,000% or higher... And, more than 675 stocks that went up 100%... Not to mention the No. 1 stock in the S&P 500 each and every year, for a decade, from 2012 to 2021. Now he’s releasing his list of the Top 11 stocks for 2023. [Click here to get this list for free.]( Today's Market-Moving News 🔎 🦅 Hawkish Fed Minutes: Minutes from last month's Fed meeting showed policymakers are committed to continuing rate hikes, initially sending stocks lower. Fed officials also noted that optimism in the markets could complicate its inflation fight. 💸 Coinbase Gets Slapped: Crypto exchange Coinbase [COIN +12.2%] settled an ongoing dispute with N.Y. regulators in exchange for a $100 million penalty. Today's Top Winners and Losers 🔥 Vera Therapeutics [VERA] $6.46 (-64.7%) Vera Therapeutics tanked despite announcing positive topline results from a Phase 2b origin clinical trial of atacicept to treat IGA nephropathy. The drug achieved a 33% mean reduction in proteinuria from baseline, and the company is planning a Phase 3 trial in the first half of 2023. ReShape Lifesciences [RSLS] $8.90 (-43.1%) ReShape Lifesciences pulled back today after a short squeeze rally sent the stock to a 132% gain on Tuesday. Enovix Corp [ENVX ://elitetra.de/L2Ic ] $7.15 (-41.0%) Enovix Corp hosted a livestream presentation to update investors on production, commercialization, and recent management additions. The market must've not liked what it heard because shares promptly plummeted on the news. Vivos Therapeutics [VVOS] $1.88 (+154.0%) The FDA awarded 510(k) clearance for Vivos Therapeutics proprietary DNA appliance, or daytime-nighttime appliance to treat sleep apnea. Reunion Neuroscience [REUN] - Last Close: $1.45 (+39.4%) Reunion Neuroscience announced that it's on track to dose the first patient in a Phase 2 study of RE104 in postpartum depression patients. Theseus Pharmaceuticals [THRX] $7.10 (+36.2%) A recent Form 4 filing revealed Foresite Capital Management, a major shareholder in Theseus Pharma, added half a million shares to its position at a cost of roughly $5 apiece for a total purchase price of $2.5 million. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](